IL-1 Signaling Regulates Skin Inflammation Through Directly Activating and Indirectly Chemoattracting Dermal Γδ T17 Cells (CAM1P.147)

Yihua Cai,Feng Xue,Na Liu,Christopher Fleming,Jun Yan

DOI: https://doi.org/10.4049/jimmunol.194.supp.48.4

2015-01-01

The Journal of Immunology

Abstract:Abstract Interleukin (IL)-1β has been demonstrated to play an important role in skin inflammation. The mechanisms by which IL-1β signaling pathway regulates skin inflammation remain elusive. Previously we have demonstrated the critical role of dermal γδ T17 cells in psoriasis pathogenesis, therefore we hypothesized that IL-1β may regulate skin inflammation through the activation of dermal γδ T cells. To test this hypothesis, we established a neonatal thymocytes reconstitution system in which IL-1R signaling is selectively deficient in dermal γδ T cells or the other cells. The reconstituted mice with IL-1R signaling specific deficiency in dermal γδ T cells showed less IL-17 production in skin compared to control mice after IMQ application, but the epidermal thickness was not significantly changed. Similar phenotype was also found in the reconstituted mice with WT dermal γδ T cells, but IL-1R deficiency in all the other cells. These results indicate that IL-1R signaling in both dermal γδ T cells and the other cells is required to induce full-fledged skin inflammation. Indeed, we found that IL-1β stimulated keratinocytes (KCs) to secrete chemokines including CCL20. Therefore, IL-1β may regulate skin inflammation at two levels: directly activating dermal γδ T17 cells and stimulating KCs to secrete chemokines which may chemoattract peripheral γδ T cells to dermis, thus amplifying the inflammatory cascade. This work is supported by a grant from National Psoriasis Foundation.